Breaking News Instant updates and real-time market news.

AMCX

AMC Networks

$53.03

0.65 (1.24%)

, LGF

Use LGF.A, LGF.B

$21.41

0.57 (2.74%)

08:25
10/06/16
10/06
08:25
10/06/16
08:25

AMC Networks initiated with an Outperform at FBN Securities

FBN Securities analyst Robert Routh initiated AMC Networks (AMCX) with an Outperform rating and a fair value estimate of $69.24. Routh calls AMC Networks "very attractive" as a possible takeover target, as he believes it could fit well with either the soon-to-be-combined Lionsgate (LGF)-Starz (STRZA) or with AT&T's (T) DTV division. Routh added that reports have indicated that AT&T is looking to grow its portfolio of TV content through deals.

AMCX

AMC Networks

$53.03

0.65 (1.24%)

LGF

Use LGF.A, LGF.B

$21.41

0.57 (2.74%)

STRZA

Starz

$32.24

0.39 (1.22%)

T

AT&T

$39.16

-0.26 (-0.66%)

  • 24

    Oct

  • 27

    Oct

AMCX AMC Networks
$53.03

0.65 (1.24%)

09/15/16
09/15/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AMC Networks (AMCX) downgraded to Hold from Buy at Stifel with analyst Benjamin Mogil citing weak industrywide ad trends for scripted shows after their first year. 2. Atara Biotherapeutics (ATRA) downgraded to Sell from Neutral at Goldman with analyst Salveen Richter saying there are no major pipeline catalysts until late 2017. 3. Helmerich & Payne (HP) downgraded to Hold from Buy at Argus with analyst Bill Selesky saying that the company is increasingly relying on lower priced spot contracts rather than higher priced term contracts. 4. Cognizant (CTSH) downgraded to Neutral from Buy at Goldman with analyst James Schneider saying cyclical headwinds in the company's Financials and Healthcare units will persist through the first ha lf of 2017. 5. Penske Automotive (PAG) downgraded to Hold from Buy at Gabelli citing the recent strength in shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/15/16
STFL
09/15/16
DOWNGRADE
STFL
Hold
AMC Networks downgraded on advertising outlook at Stifel
As noted earlier, Stifel downgraded AMC Networks to Hold from Buy. Analyst Benjamin Mogil lowered his ad estimates for the company ,citing weak industrywide ad trends for scripted shows after their first year. Mogil says that the company's ratings have been under significant pressure this year, and he expects that trend to continue.
09/15/16
STFL
09/15/16
DOWNGRADE
STFL
Hold
AMC Networks downgraded to Hold from Buy at Stifel
08/16/16
PACS
08/16/16
NO CHANGE
PACS
AMC Networks should be bought at current levels, says Pacific Crest
Pacific Crest analyst Andy Hargreaves says that AMC's stock is "overly cheap." The analyst says that the ratings of the network's "Fear the Walking Dead" show have "stabilized over the past five episodes," indicating that its "viewership declines should moderate" in the second half of its upcoming season. The analyst adds that "Walking Dead's" audience could stabilize during its upcoming season. He keeps a $72 price target and Overweight rating on the stock.
LGF Use LGF.A, LGF.B
$21.41

0.57 (2.74%)

09/23/16
PACS
09/23/16
NO CHANGE
PACS
Lionsgate Starz renewal 'better than feared but not great,' says Pacific Crest
After Liongate's (LGF) Starz announced a multi-year renewal of its deal with AT&T/DirectTV (T), Pacific Crest analysts Evan Wingren and Andy Hargreaves estimate that the agreement implies a roughly 20% decline in annual revenue compared with the previous deal. The analyst warns investors to expect similar pricing declines going forward unless Lionsgate can improve Starz's programming and integrate the asset.
09/19/16
BMUR
09/19/16
NO CHANGE
Target $27
BMUR
Buy
Lionsgate weakness would be buying opportunity, says Brean Capital
Brean Capital analyst Alan Gould said Lionsgate shares could be weak following the disappointing opening weekend for "Blair Witch" in theaters. The analyst believes any weakness is a buying opportunity. Gould cited his respect for management and its ability to execute on acquisitions. He also sees the company becoming a roll-up up vehicle for John Malone and entertainment companies. Gould reiterated his Buy rating and $27 price target on Lionsgate shares.
09/16/16
LOOP
09/16/16
NO CHANGE
Target $30
LOOP
Buy
Blair Witch could begin notable box office run for Lionsgate, says Loop Capital
Loop Capital analyst David Miller noted that the "Blair Witch" reboot debuts on 4,275 screens in North America this weekend and estimates it can open at $15M, which would be "fairly strong" for a horror film. The film, which could be profitable for Lionsgate (LGF) after only one weekend at the box office if his estimate is correct, could be the start of a "notable streak" for the company's studio, Miller tells investors. The analyst, who added that he thinks the Starz (STRZA) deal will close by November 30 at the latest, keeps a Buy rating and $30 price target on Lionsgate shares.
09/30/16
PIPR
09/30/16
NO CHANGE
Target $30
PIPR
Overweight
Lionsgate's Deepwater Horizon tracking for soft opening weekend
Piper Jaffray analyst Stan Meyers says Lionsgate's Deepwater Horizon film is tracking to open lighter than expected. Deepwater was expected to be one of top three films for Lionsgate in FY17 with initial domestic box office expectations in $80M-plus territory, but consensus expectations over the past few months have come down to the $60M level, Meyers tells investors in a research note. He notes the film is tracking to open in the $16M-$20M range this weekend, slightly below the $20M expectations. Meyers expects "some near-term headwinds" for Lionsgate shares, but he sees an attractive entry point ahead of the Starz integration. The analyst keeps an Overweight rating on Lionsgate with a $30 price target.
STRZA Starz
$32.24

0.39 (1.22%)

08/02/16
FBRC
08/02/16
NO CHANGE
Target $32
FBRC
Outperform
Lionsgate price target raised to $32 from $25 at FBR Capital
FBR Capital analyst Barton Crockett raised his price target for Lionsgate (LGF) to $32 saying he was encouraged by the cost synergy expectations disclosed yesterday in the joint Starz (STRZA)/Lionsgate merger filing. The analyst keeps an Outperform rating on Lionsgate and Market Perform rating on Starz.
08/03/16
FBNS
08/03/16
UPGRADE
FBNS
Outperform
Starz upgraded to Outperform from Sector Perform at FBN Securities
09/06/16
BMUR
09/06/16
INITIATION
BMUR
Hold
Starz initiated with a Hold at Brean Capital
Brean Capital analyst Alan Gould started Starz (STRZA) with a Hold rating saying he sees minimal upside on an arbitrage basis and "much less upside" than buying Lionsgate (LGF) directly.
T AT&T
$39.16

-0.26 (-0.66%)

09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/16
UBSW
09/28/16
DOWNGRADE
Target $43
UBSW
Neutral
AT&T downgraded to Neutral from Buy at UBS
UBS analyst John Hodulik downgraded AT&T to Neutral citing expectations for lower earnings growth. The analyst reduced his earnings estimates by 3% to reflect the "increased competitive intensity" in wireless and incremental costs associated with AT&T's DTV Now roll-out. Hodulik cut his price target for AT&T shares to $43 from $46.
09/26/16
09/26/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AT&T (T) upgraded to Hold from Reduce at HSBC. 2. Potash (POT) upgraded to Positive from Neutral at Susquehanna with analyst Don Carson citing expected benefits from the company's proposed merger with Agrium (AGU), which he sees as having relatively low antitrust risk compared to the other mega-mergers being pursued in the Ag space. 3. Oshkosh (OSK) upgraded to Overweight from Neutral at JPMorgan and to Neutral from Underperform at Credit Suisse. 4. Marriott (MAR) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Thomas Allen citing strong unit growth. 5. NetApp (NTAP) upgraded to Buy from Hold at Cross Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/16
HSBC
09/26/16
UPGRADE
Target $38
HSBC
Hold
AT&T upgraded to Hold from Reduce at HSBC
HSBC analyst Sunil Rajgopal upgraded AT&T to Hold with a $38 price target.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.